Citation Impact
Citing Papers
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Predominant Autoantibody Production by Early Human B Cell Precursors
2003 StandoutScience
Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD mice
2008 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression
2013 StandoutNobel
The microbiota regulates type 2 immunity through RORγt + T cells
2015 StandoutScienceNobel
T cell defined tumor antigens
1997
Progress in human tumour immunology and immunotherapy
2001 Nature
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Genetic effects on gene expression across human tissues
2017 StandoutNature
MHC Class II Molecules Are Not Required for Survival of Newly Generated CD4+ T Cells, but Affect Their Long-Term Life Span
1996
The biology and management of non-small cell lung cancer
2018 StandoutNature
Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance
2008 Nature
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
2011 StandoutNature
Imaging in the era of molecular oncology
2008 StandoutNature
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
2004 StandoutNature
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
A listing of human tumor antigens recognized by T cells
2001
Regulation of T cell production in T cell receptor transgenic mice
1993
Human tumor antigens recognized by T-cells
1997
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
2003 Standout
Tolerance induction by clonal deletion of CD4+8+ thymocytes in vitro does not require dedicated antigen‐presenting cells
1993 StandoutNobel
Autophagy: Renovation of Cells and Tissues
2011 Standout
The Makings of a Tumor Rejection Antigen
1999
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
Gene Switching and the Stability of Odorant Receptor Gene Choice
2004 StandoutNobel
Role of T helper cell precursor frequency on vesicular stomatitis virus neutralizing antibody responses in a T cell receptor β chain transgenic mouse
1995
A listing of human tumor antigens recognized by T cells: March 2004 update
2004
Positive selection of lymphocytes
1994
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Natural IgE Production in the Absence of MHC Class II Cognate Help
2006
The Fas Death Factor
1995 StandoutScience
Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient Mice
1997
Clonal selection and learning in the antibody system
1996 StandoutNature
The Interferon Regulatory Transcription Factor IRF-1 Controls Positive and Negative Selection of CD8+ Thymocytes
1997
A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens
1999
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
2000 StandoutNature
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Recent thymic emigrants are distinct from most medullary thymocytes
1997
In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells
1992 StandoutNobel
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide
2001
Autophagy in immunity and inflammation
2011 StandoutNature
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Positive and Negative Selection of T Cells
2003
Thymocyte development is normal in CTLA-4-deficient mice
1997 StandoutNobel
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
2005 StandoutNobel
Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice.
1994 Nobel
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4+T cell responses
1999 StandoutNobel
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
Immature surface Ig+ B cells can continue to rearrange kappa and lambda L chain gene loci.
1993
Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
1999 StandoutNobel
γc Gene Transfer in the Presence of Stem Cell Factor, FLT-3L, Interleukin-7 (IL-7), IL-1, and IL-15 Cytokines Restores T-Cell Differentiation From γc(−) X-Linked Severe Combined Immunodeficiency Hematopoietic Progenitor Cells in Murine Fetal Thymic Organ Cultures
1998
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
2000 StandoutScience
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.
1995 StandoutNobel
TNF-Mediated Toxicity After Massive Induction of Specific CD8+ T Cells Following Immunization of Mice with a Tumor-Specific Peptide
2002
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
1998 StandoutScience
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Emerging Challenges in Regulatory T Cell Function and Biology
2007 StandoutScienceNobel
Global Patterns of Linkage Disequilibrium at the CD4 Locus and Modern Human Origins
1996 StandoutScienceNobel
Receptor Selection in B and T Lymphocytes
2000
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Characterization of a single-chain T-cell receptor expressed in Escherichia coli.
1992
In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes.
1991
Immunological Memory and Protective Immunity: Understanding Their Relation
1996 StandoutScience
Reconstitution of the subclass-specific expression of CD4 in thymocytes and peripheral T cells of transgenic mice: identification of a human CD4 enhancer.
1993
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
Virus-specific CD8+ T-cell responses in mice transgenic for a T-cell receptor beta chain selected at random
1994 StandoutNobel
Autoreactive Diabetogenic T-Cells in NOD Mice Can Efficiently Expand From a Greatly Reduced Precursor Pool
2001
Works of Daniel Brändle being referenced
Regulation of RAG‐1 and CD69 expression in the thymus during positive and negative selection
1994
The shared tumor-specific antigen encoded by mouse geneP1A is a target not only for cytolytic T lymphocytes but also for tumor rejection
1998
Involvement of both T cell receptor Vα and Vβ variable region domains and α chain junctional region in viral antigen recognition
1991
A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.
1996
Engagement of the T-cell receptor during positive selection in the thymus down-regulates RAG-1 expression.
1992